PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2003. Start Trial.
Date Value
October 23, 2026 2.324
October 22, 2026 2.345
October 21, 2026 2.291
October 20, 2026 2.319
October 19, 2026 2.265
October 16, 2026 2.268
October 15, 2026 2.245
October 14, 2026 2.192
October 13, 2026 2.119
October 12, 2026 2.149
October 09, 2026 2.130
October 08, 2026 2.132
October 07, 2026 2.153
October 06, 2026 2.134
October 05, 2026 2.132
October 02, 2026 2.154
October 01, 2026 2.161
September 30, 2026 2.206
September 29, 2026 2.260
September 28, 2026 2.276
September 25, 2026 2.255
September 24, 2026 2.274
September 23, 2026 2.277
September 22, 2026 2.323
September 21, 2026 2.339
Date Value
September 18, 2026 2.30
September 17, 2026 2.338
September 16, 2026 2.303
September 15, 2026 2.290
September 14, 2026 2.292
September 11, 2026 2.204
September 10, 2026 2.204
September 09, 2026 2.227
September 08, 2026 2.223
September 04, 2026 2.285
September 03, 2026 2.330
September 02, 2026 2.310
September 01, 2026 2.320
August 31, 2026 2.301
August 28, 2026 2.328
August 27, 2026 2.302
August 26, 2026 2.355
August 25, 2026 2.385
August 24, 2026 2.371
August 21, 2026 2.400
August 20, 2026 2.380
August 19, 2026 2.422
August 18, 2026 2.343
August 17, 2026 2.303
August 14, 2026 2.268

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
AstraZeneca PLC 8.853
Johnson & Johnson 6.488
Eli Lilly & Co. 14.52
Merck & Co., Inc. 5.439
Novo Nordisk A/S 3.374

PS Ratio Related Metrics